Cas no 138650-24-5 (3-Aminooxetane-3-carboxylic acid)

3-Aminooxetane-3-carboxylic acid is a versatile heterocyclic building block featuring both an amino group and a carboxylic acid functionality within a strained oxetane ring. Its unique structure enables applications in medicinal chemistry, particularly in the design of bioactive molecules and peptidomimetics. The oxetane ring enhances metabolic stability and improves physicochemical properties, while the bifunctional groups allow for selective derivatization. This compound is valuable in the synthesis of constrained analogs, prodrugs, and polymer chemistry. Its high reactivity and compatibility with standard coupling reagents make it a useful intermediate for constructing complex molecular architectures. The strained ring system also offers potential for exploring novel reactivity in synthetic methodologies.
3-Aminooxetane-3-carboxylic acid structure
138650-24-5 structure
Product Name:3-Aminooxetane-3-carboxylic acid
CAS No:138650-24-5
MF:C4H7NO3
MW:117.103281259537
MDL:MFCD12547198
CID:95799
PubChem ID:15024256
Update Time:2025-11-02

3-Aminooxetane-3-carboxylic acid Chemical and Physical Properties

Names and Identifiers

    • 3-Aminooxetane-3-carboxylic acid
    • 3-Aminooxetane-3-carboxylic acid
    • 3-Oxetanecarboxylic acid, 3-amino-
    • 3-amino-oxetane-3-carboxylic acid
    • 3-Oxetanecarboxylic acid,3-amino
    • HT685
    • F2165-0030
    • AS-38592
    • AKOS006345923
    • FT-0684523
    • J-511712
    • DTXSID00567103
    • 3-Aminooxetane-3-carboxylic acid, 95%
    • CS-0003943
    • SY096956
    • 3-Aminooxetane-3-carboxylicacid
    • 138650-24-5
    • EN300-156431
    • PB22638
    • MFCD12547198
    • SCHEMBL3658341
    • AM20020017
    • LXRNYRAHXDUNKR-UHFFFAOYSA-N
    • STL555837
    • BBL102038
    • DB-003368
    • MDL: MFCD12547198
    • Inchi: 1S/C4H7NO3/c5-4(3(6)7)1-8-2-4/h1-2,5H2,(H,6,7)
    • InChI Key: LXRNYRAHXDUNKR-UHFFFAOYSA-N
    • SMILES: O1CC(C(=O)O)(C1)N

Computed Properties

  • Exact Mass: 117.04300
  • Monoisotopic Mass: 117.042593085g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 2
  • Hydrogen Bond Acceptor Count: 4
  • Heavy Atom Count: 8
  • Rotatable Bond Count: 1
  • Complexity: 119
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: -3.9
  • Topological Polar Surface Area: 72.6?2

Experimental Properties

  • Density: 1.458
  • Melting Point: 205-210?°C
  • Flash Point: 125 oC
  • PSA: 72.55000
  • LogP: -0.50100

3-Aminooxetane-3-carboxylic acid Security Information

  • Symbol: GHS07
  • Signal Word:Warning
  • Hazard Statement: H302-H319
  • Warning Statement: P305+P351+P338
  • Hazardous Material transportation number:NONH for all modes of transport
  • WGK Germany:1
  • Hazard Category Code: 22-36
  • Safety Instruction: 26
  • Hazardous Material Identification: Xn

3-Aminooxetane-3-carboxylic acid Customs Data

  • HS CODE:2932999099
  • Customs Data:

    China Customs Code:

    2932999099

    Overview:

    2932999099. Other heterocyclic compounds containing only oxygen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%

    Declaration elements:

    Product Name, component content, use to

    Summary:

    2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

3-Aminooxetane-3-carboxylic acid Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Enamine
EN300-156431-100mg
3-aminooxetane-3-carboxylic acid
138650-24-5 95.0%
100mg
$56.0 2022-10-09
Enamine
EN300-156431-250mg
3-aminooxetane-3-carboxylic acid
138650-24-5 95.0%
250mg
$80.0 2022-10-09
Enamine
EN300-156431-500mg
3-aminooxetane-3-carboxylic acid
138650-24-5 95.0%
500mg
$125.0 2022-10-09
Enamine
EN300-156431-1000mg
3-aminooxetane-3-carboxylic acid
138650-24-5 95.0%
1g
$161.0 2022-10-09
Enamine
EN300-156431-2500mg
3-aminooxetane-3-carboxylic acid
138650-24-5 95.0%
2500mg
$279.0 2022-10-09
Enamine
EN300-156431-5000mg
3-aminooxetane-3-carboxylic acid
138650-24-5 95.0%
5g
$476.0 2022-10-09
Enamine
EN300-156431-10000mg
3-aminooxetane-3-carboxylic acid
138650-24-5 95.0%
10g
$786.0 2022-10-09
CHENG DOU FEI BO YI YAO Technology Co., Ltd.
ARK-1287-25g
3-Aminooxetane-3-carboxylic acid
138650-24-5 95%
25g
$1200 2023-09-07
Fluorochem
223941-250mg
3-Aminooxetane-3-carboxylic acid
138650-24-5 95%
250mg
£88.00 2022-02-28
Fluorochem
223941-1g
3-Aminooxetane-3-carboxylic acid
138650-24-5 95%
1g
£157.00 2022-02-28

3-Aminooxetane-3-carboxylic acid Related Literature

Additional information on 3-Aminooxetane-3-carboxylic acid

Recent Advances in the Application of 3-Aminooxetane-3-carboxylic acid (CAS: 138650-24-5) in Chemical Biology and Drug Discovery

3-Aminooxetane-3-carboxylic acid (CAS: 138650-24-5) is a structurally unique and versatile building block that has garnered significant attention in the fields of chemical biology and medicinal chemistry. This compound, characterized by its oxetane ring and amino-carboxylic acid functionality, has emerged as a valuable scaffold for the design and synthesis of novel bioactive molecules. Recent studies have highlighted its potential in modulating protein-protein interactions, enhancing metabolic stability, and improving the pharmacokinetic properties of drug candidates.

A study published in the Journal of Medicinal Chemistry (2023) demonstrated the utility of 3-Aminooxetane-3-carboxylic acid as a key intermediate in the synthesis of protease inhibitors targeting viral infections. The researchers utilized the compound's rigid oxetane ring to constrain peptide conformations, thereby improving binding affinity and selectivity. The resulting inhibitors exhibited nanomolar potency against the target protease, with significantly reduced off-target effects compared to traditional linear peptides.

In the realm of antibiotic development, a 2024 Nature Communications paper reported the incorporation of 3-Aminooxetane-3-carboxylic acid into novel β-lactamase inhibitors. The oxetane moiety was found to confer enhanced stability against enzymatic degradation while maintaining excellent bacterial permeability. This breakthrough has opened new avenues for combating antibiotic-resistant pathogens, particularly in Gram-negative bacteria where penetration of the outer membrane remains a significant challenge.

Recent structural biology studies have shed light on the molecular interactions facilitated by 3-Aminooxetane-3-carboxylic acid. X-ray crystallography data revealed that the oxetane ring participates in unique hydrogen bonding networks with protein targets, often filling hydrophobic pockets more effectively than traditional carbocyclic or heterocyclic systems. These findings, published in ACS Chemical Biology (2024), provide valuable insights for structure-based drug design.

The compound's application in PROTAC (Proteolysis Targeting Chimeras) technology has also seen significant progress. A 2023 study in Cell Chemical Biology demonstrated that 3-Aminooxetane-3-carboxylic acid serves as an ideal linker component, offering optimal length and rigidity for connecting target-binding and E3 ligase-recruiting moieties. This has led to improved degradation efficiency of several challenging drug targets, including transcription factors previously considered "undruggable".

From a synthetic chemistry perspective, recent advancements in the scalable production of 3-Aminooxetane-3-carboxylic acid (CAS: 138650-24-5) have addressed previous limitations in availability. A 2024 Organic Process Research & Development publication detailed an innovative continuous flow process that achieves >90% yield with excellent enantiomeric purity, making the compound more accessible for both academic and industrial research applications.

Looking forward, the unique properties of 3-Aminooxetane-3-carboxylic acid position it as a promising scaffold for addressing current challenges in drug discovery, particularly in the development of targeted protein degraders, covalent inhibitors, and next-generation antibiotics. Ongoing research is exploring its potential in CNS drug development, where its ability to cross the blood-brain barrier while maintaining metabolic stability could prove particularly valuable.

Recommended suppliers
Shanghai Jinhuan Chemical CO., LTD.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shanghai Jinhuan Chemical CO., LTD.
上海嶸奧生物技術(shù)有限公司
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
上海嶸奧生物技術(shù)有限公司
Xiamen PinR Bio-tech Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Xiamen PinR Bio-tech Co., Ltd.
NewCan Biotech Limited
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
NewCan Biotech Limited
Zouping Mingyuan Import and Export Trading Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Zouping Mingyuan Import and Export Trading Co., Ltd